论文部分内容阅读
目的:分析恶性肿瘤化疗患者医院真菌感染的临床特点及治疗对策。方法:选取2014年1月—2015年6月间接受化疗且并发真菌感染的恶性肿瘤患者52例临床资料,分析其真菌感染的临床特点。结果:呼吸道真菌感染是恶性肿瘤患者化疗期间最易出现部位,占总感染率的59.62%;其次是消化道占23.08%,泌尿道占9.62%;感染的真菌主要为白色假丝酵母菌占55.77%,其次热带假丝酵母菌占23.08%,克柔假丝酵母菌占7.69%;伴有慢性疾病的患者更易发生真菌感染,肿瘤分期越晚,感染概率越大。结论:呼吸道是恶性肿瘤化疗患者感染真菌的主要部位,白色假丝酵母菌是其感染的主要病原体,因此临床上应根据这一结果做好相应的防治对策。
Objective: To analyze the clinical characteristics and treatment of hospital fungal infection in patients with malignant tumor chemotherapy. Methods: Clinical data of 52 patients with malignant tumor who underwent chemoradiotherapy and concurrent fungal infection from January 2014 to June 2015 were selected and the clinical features of fungal infection were analyzed. Results: Respiratory fungal infection was the most likely site of malignant tumor during chemotherapy, accounting for 59.62% of the total infection rate; followed by gastrointestinal tract accounted for 23.08%, urinary tract accounted for 9.62%; infected fungi mainly Candida albicans accounted for 55.77 %, Followed by Candida tropicalis accounted for 23.08%, Candida krusei 7.69%; patients with chronic diseases more susceptible to fungal infection, the more advanced stage of the tumor, the greater the probability of infection. Conclusion: The respiratory tract is the main site of fungal infection in patients with malignant tumors chemotherapy, Candida albicans is the main pathogen of infection, so the clinical should be based on this result to make appropriate control strategies.